These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19504239)

  • 1. Selecting the "right" mouse model for metabolic syndrome and type 2 diabetes research.
    Leiter EH
    Methods Mol Biol; 2009; 560():1-17. PubMed ID: 19504239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and genetics of obesity and diabetes in the New Zealand obese mouse: a model of the human metabolic syndrome.
    Kluge R; Scherneck S; Schürmann A; Joost HG
    Methods Mol Biol; 2012; 933():59-73. PubMed ID: 22893401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome.
    Joost HG
    Results Probl Cell Differ; 2010; 52():1-11. PubMed ID: 20865367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are animal models of diabetes relevant to the study of the genetics of non-insulin-dependent diabetes in humans?
    Ktorza A; Bernard C; Parent V; Penicaud L; Froguel P; Lathrop M; Gauguier D
    Diabetes Metab; 1997 Mar; 23 Suppl 2():38-46. PubMed ID: 9105782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental rat models to study the metabolic syndrome.
    Aleixandre de Artiñano A; Miguel Castro M
    Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes.
    Ohnishi T; Bandow K; Kakimoto K; Machigashira M; Matsuyama T; Matsuguchi T
    J Periodontal Res; 2009 Feb; 44(1):43-51. PubMed ID: 18973548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives.
    Plum L; Wunderlich FT; Baudler S; Krone W; Brüning JC
    Physiology (Bethesda); 2005 Jun; 20():152-61. PubMed ID: 15888572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key.
    Hattersley AT
    J Clin Invest; 2004 Aug; 114(3):314-6. PubMed ID: 15286795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions.
    Leiter EH
    Diabetologia; 2002 Mar; 45(3):296-308. PubMed ID: 11914735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of animal models in the study of diabetes mellitus.
    Chatzigeorgiou A; Halapas A; Kalafatakis K; Kamper E
    In Vivo; 2009; 23(2):245-58. PubMed ID: 19414410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models created to study the pathophysiology of Type 2 diabetes.
    LeRoith D; Gavrilova O
    Int J Biochem Cell Biol; 2006; 38(5-6):904-12. PubMed ID: 16103004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic animal models for the study of adipose tissue biology.
    Blüher M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):605-23. PubMed ID: 16311220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus.
    Stephens JW; Hurel SJ; Lowe GD; Rumley A; Humphries SE
    Mol Genet Metab; 2007 Apr; 90(4):422-8. PubMed ID: 17123852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome.
    Huber M; Heiduschka P; Ziemssen F; Bolbrinker J; Kreutz R
    Hypertens Res; 2011 Jan; 34(1):103-12. PubMed ID: 20927114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
    Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat models of the metabolic syndrome.
    Tofovic SP; Jackson EK
    Methods Mol Med; 2003; 86():29-46. PubMed ID: 12886760
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic analysis of a new mouse model for non-insulin-dependent diabetes.
    Kim JH; Sen S; Avery CS; Simpson E; Chandler P; Nishina PM; Churchill GA; Naggert JK
    Genomics; 2001 Jun; 74(3):273-86. PubMed ID: 11414755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
    Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
    Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of human genetic disease: which mouse is more like a man?
    Erickson RP
    Bioessays; 1996 Dec; 18(12):993-8. PubMed ID: 8976156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.